Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Software AG is a global enterprise software company headquartered in Germany, specializing in business process management, IoT, and enterprise architecture. While not a primary biotechnology or pharmaceutical developer, the company provides critical digital infrastructure for the life sciences sector through its 'Connected Healthcare' and 'Digital Pharma' solutions. Its platforms, such as ARIS and Alfabet, are utilized by major pharmaceutical firms to ensure regulatory compliance, optimize manufacturing workflows, and manage complex IT landscapes. The company's IoT capabilities support the development of connected medical devices and real-time supply chain monitoring for temperature-sensitive biologics. In 2023, Software AG was acquired by the private equity firm Silver Lake and subsequently delisted from the Frankfurt Stock Exchange. Following the acquisition, the company divested its webMethods and StreamSets business units to IBM to focus on its core business transformation and IoT portfolios.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Software AG.